A simple and rapid high-performance liquid chromatographic method for the determination of bisoprolol fumarate and hydrochlorothiazide in a tablet dosage form

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 3, 2008, Pages 1055-1057

  Shaikh, Saleem ^a   Thusleem, O A ^a   Muneera, M S ^a   Akmal, Javeed ^a   Kondaguli, Anand V ^a   Ruckmani, K ^b  

^a Jamjoom Pharmaceuticals   (Saudi Arabia)

^b ANNA UNIVERSITY   (India)

Author keywords

Bisoprolol fumarate; Hydrochlorothiazide; Isocratic; Peak elution; Reverse phase chromatography; Simultaneous determination

Indexed keywords

ACETONITRILE; AEROSIL; BISOPROLOL FUMARATE; CALCIUM PHOSPHATE DIBASIC; CROSSPOVIDONE; EXCIPIENT; HYDROCHLOROTHIAZIDE; MAGNESIUM STEARATE; MAIZE STARCH; MCC PH102; NITRILE; PHOSPHATE BUFFERED SALINE; TETRAHYDROFURAN; UNCLASSIFIED DRUG;

ACCURACY; AQUEOUS SOLUTION; ARTICLE; CORRELATION COEFFICIENT; DRUG DETERMINATION; ELUTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TABLET; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ACETONITRILES; ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; BUFFERS; CHLOROTHIAZIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIURETICS; DOSAGE FORMS; DRUG CONTAMINATION; FURANS; GUIDELINES AS TOPIC; HYDROCHLOROTHIAZIDE; PHOSPHATES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS; TEMPERATURE; TIME FACTORS; WATER;

EID: 53049104671     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.08.009     Document Type: Article

References (12)

1. Bhatt J., Subbaiah G., Kambli S., Shah B., Patel M., Saxena A., Baliga A., Nigam S., Parekh H., and Yadav G. J. Chromatogr. B. 852 (2007) 374-381
2. Bueno Rolim C.M., Brum Jr. L., Fronza M., Malesuik M.D., Bajerski L., and Dalmora S.L. J. Liq. Chromatogr. Relat. Technol. 28 (2005) 477-486
3. Hefnawy M.M., Sultan M.A.-A., and Al-Shehri M.M. Chem. Pharm. Bull. 55 (2007) 227-230
4. Chen Z., Zeng S., and Yao T. Pharmazie 62 (2007) 585-592
5. Shah S.A., Rathod I.S., Suhagia B.N., Savale S.S., and Patel J.B. J. AOAC Int. 84 (2001) 1715-1723
6. Medvedovici A., Mircioiu C., David V., and Miron D.S. Eur. J. Drug Metab. Pharmacokin. 25 (2000) 91-96
7. Qutab S.S., Razzaq S.N., Ashfaq M., Shuja Z.A., and Khan I.U. Acta Chromatogr. 19 (2007) 119-129
8. Shankar M.B., Mehta F.A., Bhatt K.K., Mehta R.S., and Geetha M. Indian J. Pharm. Sci. 65 (2003) 167-171
9. Ivanovic D., Medenica M., Malenovic A., and Jancic B. Accredit. Qual. Assur.: J. Qual. Comparab. Reliab. Chem. Meas. 9 (2004) 76-81
10. Patel L.J., Suhagia B.N., Shah P.B., and Shah R.R. Indian J. Pharm. Sci. 68 (2006) 635-638
11. USP 31 NF 26, United States Pharmacopoeia U.S. Pharmacopeial Convention, Inc., Rockville, MD, 2008.
12. ICH Harmonized Tripartite Guideline, International Conference on Harmonization on Technical Requirements for Registration of Pharmaceuticals for Human Use, Q2A, Text on Validation of Analytical Procedures, Step 4 of the ICH process (1994) and Q2B, Validation of Analytical Procedures: Methodology, Step 4 of the ICH process, ICH Steering Committee (1996) International Conference on Harmonization, Geneva, Switzerland.